Key Takeaways
- Shares of UiPath declined 7.7% on Wednesday, dropping to an intraday low of $11.00 from the previous session’s close of $12.04.
- Trading volume was exceptionally thin at 85% below typical levels, with only 6.4 million shares exchanged.
- Analyst consensus remains at “Hold” with an average price target of $13.80 across 17 covering analysts.
- The company’s most recent quarterly results showed revenue of $418.38 million, representing 17.3% year-over-year growth and exceeding forecasts.
- Convergence Investment Partners established a fresh stake worth $4.4 million during the first quarter.
Shares of UiPath (PATH) experienced a sharp decline on Wednesday, falling 7.7% as the automation software company touched $11.00 during intraday trading before settling at $11.11. The session began with the stock closing the prior day at $12.04.
The decline was particularly notable given the exceptionally thin trading activity. Approximately 6.4 million shares exchanged hands throughout the session — representing an 85% reduction compared to the typical daily volume of 41.4 million shares. Such reduced liquidity can amplify price movements and create exaggerated volatility.
Technical indicators show the stock trading right at its 50-day moving average of $11.11, while the 200-day moving average registers at $11.75. The company currently maintains a market capitalization of roughly $5.50 billion.
Analyst Sentiment Remains Neutral
The Wall Street analyst community maintains a predominantly cautious stance on PATH. Among 17 analysts tracking the stock, 14 have assigned “Hold” ratings, while two recommend “Buy” and one maintains a “Sell” rating. The average price target across all analysts stands at $13.80.
Recent analyst activity has trended toward the conservative side. BMO Capital Markets lowered its price objective from $14 to $13 while maintaining a “market perform” stance. Morgan Stanley reduced its target from $17 down to $15 with an “equal weight” designation. UBS adjusted its target downward from $13 to $12 while maintaining a “neutral” rating. Bank of America modestly increased its target from $12 to $13 but retained an “underperform” rating.
Needham stands out as the most bullish firm, reaffirming its “buy” recommendation with a $15 price objective.
Financial Performance Exceeded Expectations
The stock’s weakness appears disconnected from PATH‘s actual financial performance, which was reported in late May. The company delivered quarterly revenue of $418.38 million, comfortably surpassing the analyst consensus estimate of $397.54 million. This figure marked a 17.3% increase compared to the year-ago period.
Earnings per share reached $0.15, aligning precisely with analyst projections. The comparable quarter in the previous year produced EPS of $0.11. The company achieved a net margin of 19.58% and generated a return on equity of 7.92%.
Looking ahead to the complete fiscal year, Wall Street expects earnings per share of $0.40.
The stock’s 52-week trading range spans from a low of $9.20 to a high of $19.84 — placing Wednesday’s closing price significantly below the upper end of that range.
Regarding institutional ownership, Convergence Investment Partners established a new position during the first quarter, purchasing 396,363 shares valued at approximately $4.4 million, representing roughly 0.08% of outstanding shares. Institutional investors as a group control 62.50% of the company’s stock.
Additional smaller investment firms initiated positions during the fourth quarter, including HighMark Wealth Management, Raleigh Capital Management, and Atlas Capital Advisors, each with positions valued below $40,000.
PATH concluded Wednesday’s session at $11.11, positioned precisely at its 50-day moving average.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
